Boswellia Serrata Extract in Acute Diarrhea
Not Applicable
Completed
- Conditions
- Acute DiarrheaBoswellia Serrata
- Interventions
- Dietary Supplement: lecithin-based delivery form of Boswellia serrataCombination Product: Placebo
- Registration Number
- NCT05345028
- Lead Sponsor
- Azienda di Servizi alla Persona di Pavia
- Brief Summary
Acute diarrhea is a frequent problem worldwide, mostly due to gastrointestinal infections or food poisoning. Boswellia serrata could be active in the treatment of acute diarrhea due to its an-ti-inflammatory, antispasmodic and antimicrobial activity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 49
Inclusion Criteria
- presence of acute diarrhea of mild to moderate severity
Exclusion Criteria
- patients with long term diarrhea
- iatrogenic diarrhea
- symptoms of functional gut disease or severe inter-current diseases
- severe diarrhea and dehydration requiring hospitalization and intravenous treatment
- subjects with high temperature (> 38.5° C)
- subjects treated by other anti-diarrheal and antibiotic drugs in the last 24 hours
- severely malnourished subjects
- pregnant women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Boswellia Phytosome lecithin-based delivery form of Boswellia serrata - Placebo Placebo -
- Primary Outcome Measures
Name Time Method Stoppage of diarrhea From baseline to 5 days the occurrence of the first formed stool or a period of 12 hours without any liquid or soft stools
- Secondary Outcome Measures
Name Time Method Self-assessed symptoms After 5 days percentage of subjects without diarrhea within 5 days of treatment
Trial Locations
- Locations (1)
Azienda di Servizi alla Persona
🇮🇹Pavia, Italy